Financial Survey: Avita Medical (NASDAQ:RCEL) versus Nanovibronix (NASDAQ:FEED)

Nanovibronix (NASDAQ:FEED) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Earnings & Valuation

This table compares Nanovibronix and Avita Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$1.93 million	1.74	-$18.18 million	($9.77)	-0.37
Avita Medical	$71.61 million	4.37	-$48.59 million	($1.44)	-7.06

Nanovibronix has higher earnings, but lower revenue than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations and price targets for Nanovibronix and Avita Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Avita Medical	1	1	5	0	2.57

Avita Medical has a consensus price target of $11.40, indicating a potential upside of 12.20%. Given Avita Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Avita Medical is more favorable than Nanovibronix.

Volatility & Risk

Nanovibronix has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Avita Medical has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500.

Insider & Institutional Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 12.2% of Nanovibronix shares are owned by company insiders. Comparatively, 2.2% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Nanovibronix and Avita Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-1,093.61%	-60.73%	-48.48%
Avita Medical	-56.96%	N/A	-78.53%

Summary

Avita Medical beats Nanovibronix on 10 of the 14 factors compared between the two stocks.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.

About Avita Medical

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.